S7.9.1.2-14. Olde Nordkamp LR, Postema PG, Knops RE, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016;13:443 54. S7.9.1.2-15. Roses-Noguer F, Jarman JW, Clague JR, et al. Outcomes of defi- brillator therapy in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2014;11:58 66. S7.9.1.2-16. Sy RW, Gollob MH, Klein GJ, et al. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ven- tricular tachycardia. Heart Rhythm. 2011;8:864 71. S7.9.1.2-17. De Ferrari GM, Dusi V, Spazzolini C, et al. Clinical manage- ment of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation. 2015;131:2185 93. S7.9.1.2-18. Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachy- cardia. N Engl J Med. 2008;358:2024 9. S7.9.1.2-19. Zhang C, Kutyifa V, Moss AJ, et al. Long-QT syndrome and therapy for attention deficit/hyperactivity disorder. J Cardiovasc Electrophysiol. 2015;26:1039 44. S7.9.1.2-20. Jabbari J, Jabbari R, Nielsen MW, et al. New exome data ques- tion the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia. Circ Cardiovasc Genetics. 2013;6:481 9. S7.9.1.2-21. Crotti L, Johnson CN, Graf E, et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013;127:1009 17. S7.9.1.2-22. Makita N, Yagihara N, Crotti L, et al. Novel calmodulin muta- tions associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet. 2014;7:466 74. S7.9.1.2-23. Marsman RF, Barc J, Beekman L, et al. A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrilla- tion in childhood and adolescence. J Am Coll Cardiol. 2014;63: 259 66. S7.9.1.2-24. Nyegaard M, Overgaard MT, Sondergaard MT, et al. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet. 2012;91:703 12. S7.9.1.2-25. Paludan-Muller C, Ahlberg G, Ghouse J, et al. 